Table 2. Prescribed statins of the patients by LDL-C reduction group.
| Statin therapy | Better-than-expected efficacy group | Known efficacy group |
|---|---|---|
| N (%) | N (%) | |
| Atorvastatin (10 mg) | 209 (20.99) | 441 (35.6) |
| Atorvastatin (20 mg) | 72 (7.23) | 57 (4.6) |
| Fluvastatin XL (80 mg) | 2 (0.20) | 16 (1.29) |
| Pitavastatin (2 mg) | 99 (9.94) | 225 (18.16) |
| Pitavastatin (4 mg) | 8 (0.80) | 14 (1.13) |
| Pravastatin (40 mg) | 20 (2.01) | 95 (7.67) |
| Rosuvastatin (10 mg) | 500 (50.20) | 284 (22.92) |
| Rosuvastatin (5 mg) | 29 (2.91) | 33 (2.66) |
| Simvastatin (20 mg) | 56 (5.62) | 72 (5.81) |
| Simvastatin (40 mg) | 1 (0.10) | 2 (0.16) |
| Total | 996 (100.00) | 1,239 (100.00) |
N = the number of patients.